Executive Committee (EC)
The EC is responsible for the overall management, oversight and reporting of the trial.
| Members |
|
|
| Robert Califf |
US |
Cardiologist (Co-Chair) |
| Rury Holman |
UK |
Endocrinologist (Co-Chair) |
| |
|
|
| Paul Armstong |
Canada |
Cardiologist |
| John Buse |
US |
Endocrinologist |
| Robert Josse |
Canada |
Endocrinologist |
| John Lachin |
US |
Statistician |
| Darren McGuire |
US |
Cardiologist |
| Eberhard Standl |
Germany |
Endocrinologist |
| Frans Van de Werf |
Belgium |
Cardiologist |
| |
|
|
| Barry Goldstein |
US |
Merck |
| Joerg Koglin |
US |
Merck |
| Deborah Shapiro |
US |
Merck |
| Robert Silverman |
US |
Merck |
Data Safety Monitoring Board (DSMB)
The DSMB will help ensure the safety of the trial participants by undertaking regular independent evaluation of trial safety data.
| Members |
|
|
| Marc Pfeffer |
US |
Cardiologist (Chair) |
| Hertzel Gerstein |
Canada |
Endocrinologist |
| Leif Groop |
Sweden |
Endocrinologist |
| John McMurray |
UK |
Cardiologist |
| Stuart Pocock |
UK |
Statistician |
Operations Committee (OC)
The OC is comprised of country lead investigators selected by the Executive Committee, DTU and DCRI. The primary role of the OC is to serve as the interface
between the EC and the trial sites and to monitor and supervise the progress of the
trial at a regional level.
Study Sponsor
Merck
|
About the DTU
› Home page
Software
› HOMA Calculator
